COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ)
$12.1 0.15 (1.2552%)
Analysed COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ) News Sources
Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds Build
09-03-2026
yahoo.com
Vanderbilt Report: Coeptis Therapeutics Shareholders Approve Transformational Merger: From Biopharma to Dual-Sector Platform
04-02-2026
yahoo.com
CSG Systems International Extraordinary General Meeting: Shareholders Back Key Proposals, Merger Actions
30-01-2026
marketbeat.com
Coeptis Therapeutic Holdings Details $835M Transaction Structure with Z-Squared; Vanderbilt Report Publishes Coverage
06-01-2026
yahoo.com
Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage
01-10-2025
yahoo.com
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
22-07-2025
yahoo.com
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
28-05-2025
yahoo.com
What is the current price of COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ)?
The current price of COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ) is $12.1.
COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ) absolute price change since previous trading day?
The absolute price change of COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ) since the previous trading day is $0.15.
COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ) percentage price change since previous trading day?
The percentage price change of COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ) since the previous trading day is 1.2552%.
What is the most recent average sentiment score for COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ)?
The most recent average sentiment score for COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ)?
The most recent sentiment for COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ) is .
SEC-8K** Filing Available For COEPTIS THERAPEUTICS HOLDING (COEP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.